These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38804839)

  • 1. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
    Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
    Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular primary cutaneous melanoma is associated with PD-L1 expression.
    Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Rodig S; Mihm M; Festa Neto C; Duncan LM; Kalil J
    Eur J Dermatol; 2020 Aug; 30(4):352-357. PubMed ID: 32969795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4
    Di Gennaro P; Gerlini G; Urso C; Sestini S; Brandani P; Pimpinelli N; Borgognoni L
    Clin Exp Metastasis; 2016 Dec; 33(8):787-798. PubMed ID: 27475809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.
    Berghoff AS; Ricken G; Widhalm G; Rajky O; Dieckmann K; Birner P; Bartsch R; Höller C; Preusser M
    Histopathology; 2015 Jan; 66(2):289-99. PubMed ID: 25314639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma.
    Malvehy J; Samoylenko I; Schadendorf D; Gutzmer R; Grob JJ; Sacco JJ; Gorski KS; Anderson A; Pickett CA; Liu K; Gogas H
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33785610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immune microenvironment in gastrointestinal stromal tumours.
    Blakely AM; Matoso A; Patil PA; Taliano R; Machan JT; Miner TJ; Lombardo KA; Resnick MB; Wang LJ
    Histopathology; 2018 Feb; 72(3):405-413. PubMed ID: 28871595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer.
    Goto R; Hirota Y; Aruga T; Horiguchi S; Miura S; Nakamura S; Takimoto M
    Breast Cancer; 2020 Jul; 27(4):586-593. PubMed ID: 31933123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy.
    Falk H; Matthiessen LW; Wooler G; Gehl J
    Acta Oncol; 2018 Mar; 57(3):311-319. PubMed ID: 28816072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive upregulation of PD-1 in primary and metastatic melanomas associated with blunted TCR signaling in infiltrating T lymphocytes.
    Chapon M; Randriamampita C; Maubec E; Badoual C; Fouquet S; Wang SF; Marinho E; Farhi D; Garcette M; Jacobelli S; Rouquette A; Carlotti A; Girod A; Prévost-Blondel A; Trautmann A; Avril MF; Bercovici N
    J Invest Dermatol; 2011 Jun; 131(6):1300-7. PubMed ID: 21346771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
    Donia M; Junker N; Ellebaek E; Andersen MH; Straten PT; Svane IM
    Scand J Immunol; 2012 Feb; 75(2):157-67. PubMed ID: 21955245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationships between PD-L1 expression, CD8+ TILs and clinico-histomorphological parameters in malignant melanomas.
    Škuciová V; Drahošová S; Výbohová D; Cígerová V; Adamkov M
    Pathol Res Pract; 2020 Sep; 216(9):153071. PubMed ID: 32825944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumour immune landscape and its implications in cutaneous melanoma.
    Attrill GH; Ferguson PM; Palendira U; Long GV; Wilmott JS; Scolyer RA
    Pigment Cell Melanoma Res; 2021 May; 34(3):529-549. PubMed ID: 32939993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas.
    Duverger L; Osio A; Cribier B; Mortier L; De Masson A; Basset-Seguin N; Lebbé C; Battistella M
    Cancer Immunol Immunother; 2019 Jun; 68(6):951-960. PubMed ID: 30953116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma - a case report.
    Falk H; Lambaa S; Johannesen HH; Wooler G; Venzo A; Gehl J
    Acta Oncol; 2017 Aug; 56(8):1126-1131. PubMed ID: 28562201
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
    Hussein MR; Elsers DA; Fadel SA; Omar AE
    J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4
    Mastracci L; Fontana V; Queirolo P; Carosio R; Grillo F; Morabito A; Banelli B; Tanda E; Boutros A; Dozin B; Gualco M; Salvi S; Romani M; Spagnolo F; Poggi A; Pistillo MP
    Cancer Immunol Immunother; 2020 Apr; 69(4):653-662. PubMed ID: 32025849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.